FDA Approves Afrezza For Diabetes Treatment

June 28, 2014 8:07 AM

21 0

The U.S. Food and Drugs Administration has approved a new inhaled insulin named Afrezza for treating patients with diabetes.

The new treatment improves glycemic control in adults with diabetes mellitus. Afrezza need to be taken at the beginning of each meal, or within 20 minutes after starting a meal, the FDA reports.

Read more

To category page